LON:AGL ANGLE - AGL Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ANGLE plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 29 -0.50 (-1.69%) (As of 02/1/2023 10:40 AM ET) Add Compare Share Share Today's Range 27.05▼ 29.7550-Day Range 24▼ 5652-Week Range 22.20▼ 163.75Volume2.08 million shsAverage Volume5.97 million shsMarket Capitalization£75.57 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 120 ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlines About ANGLE (LON:AGL) StockANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.Read More Receive AGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter. Email Address AGL Stock News HeadlinesJanuary 13, 2023 | foxnews.comWWE legend Kurt Angle credits daughter with saving him from drowning in scary jet ski incidentJanuary 5, 2023 | proactiveinvestors.comANGLE says it sees significant expansion opportunities for the streamlined business as it moves into 2023February 1, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 5, 2023 | finance.yahoo.comAngle plc Announces Appointment of Non-Executive DirectorDecember 12, 2022 | finance.yahoo.comAngle PLC Announces Two Parsortix Posters Presented at SABCSNovember 2, 2022 | proactiveinvestors.comANGLE says Parsortix system used for multiple tests in breast cancer studyNovember 2, 2022 | finance.yahoo.comAngle PLC Announces Multiple Downstream Analysis Techniques for CTCsOctober 12, 2022 | proactiveinvestors.comANGLE inks first regional distribution deal for breakthrough liquid biopsy systemFebruary 1, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.October 12, 2022 | finance.yahoo.comAngle PLC Announces First Regional Distribution AgreementSeptember 28, 2022 | msn.comHow to Manage Deadstick ApproachesSeptember 28, 2022 | finance.yahoo.comAngle PLC announces Study using Parsortix in head and neck cancerSeptember 12, 2022 | finanznachrichten.deANGLE plc: Angle PLC Announces Novel Assay; Predicts Malignancy in Pelvic MassSeptember 12, 2022 | finance.yahoo.comAngle PLC Announces Novel Assay; Predicts Malignancy in Pelvic MassSeptember 2, 2022 | morningstar.comAngle PLC Announces Notice of Interim Results and Webcast | MorningstarAugust 13, 2022 | finance.yahoo.comANGLE plc (AGL.L)June 29, 2022 | finance.yahoo.comAngle PLC Announces Result of 2022 Annual General MeetingJune 27, 2022 | finanznachrichten.deANGLE plc: Angle PLC Announces Spread of Breast Cancer Accelerates During SleepJune 22, 2022 | proactiveinvestors.comANGLE says second pharma services contract shows confidence in 'totally new approach'June 22, 2022 | proactiveinvestors.comANGLE lands repeat business with pharma client - Proactive Investors USAJune 22, 2022 | finance.yahoo.comAngle PLC Announces Secured Contract From Pharma Services CustomerJune 17, 2022 | finanznachrichten.deANGLE plc: Angle PLC Announces Predicting Immunotherapy Response in SCLCJune 16, 2022 | proactiveinvestors.comANGLE: Researchers highlight potential of company's liquid biopsy in lung cancerJune 16, 2022 | apnews.comAngle PLC Announces Predicting Immunotherapy Response in SCLCJune 15, 2022 | finance.yahoo.comAngle PLC Announces Potential Role of Invasive Cellular ProtrusionsJune 14, 2022 | finanznachrichten.deANGLE plc: Angle PLC Announces Potential Role of Invasive Cellular ProtrusionsMay 30, 2022 | ca.proactiveinvestors.comANGLE inks prostate cancer study agreement with US healthcare group and its affiliateSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter. Email Address AGL Company Calendar Last Earnings1/30/2020Today2/01/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Medical Laboratories & Research Sub-IndustryN/A SectorMedical Current SymbolLON:AGL CUSIPN/A CIKN/A Webwww.angleplc.com Phone+44-1483-685830FaxN/AEmployees102Year FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 120 High Stock Price ForecastGBX 120 Low Stock Price ForecastGBX 120 Forecasted Upside/Downside+313.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio16.43 Current Ratio6.55 Quick Ratio6.18 Sales & Book Value Annual Sales£1.14 million Price / Sales66.52 Cash FlowGBX 5 per share Price / Cash Flow5.80 Book ValueGBX 13.60 per share Price / Book2.13Miscellaneous Outstanding Shares260,581,000Free FloatN/AMarket Cap£75.57 million OptionableNot Optionable BetaN/A Key ExecutivesMr. Andrew David William Newland (Age 61)Founder, CEO & Exec. Director Comp: $446kMr. Ian Francis Griffiths (Age 58)CFO, Fin. Director, Company Sec. & Exec. Director Comp: $284kMr. Martin Cooke (Age 54)Director of Operations & Regulatory Affairs Mr. Andrew John Holder (Age 55)Head of Investor Relations Mr. Paul SmithChief Commercial OfficerDr. Madeline RepolletHead of Clinical LaboratoriesMs. Anne-Sophie Pailhes-JimenezHead of R&D - ANGLE Europe Ltd.Mr. Michael O'BrienBus. Devel. DirectorMore ExecutivesKey CompetitorsArecor TherapeuticsLON:ARECSareumLON:SARSourcebio InternationalLON:SBIOpen OrphanLON:ORPHDiaceuticsLON:DXRXView All CompetitorsInsiders & InstitutionsAndrew D NewlandBought 125,000 shares on 7/19/2022Total: £10 M ($80.00/share)View All Insider Transactions AGL Stock - Frequently Asked Questions Should I buy or sell ANGLE stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ANGLE in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AGL shares. View AGL analyst ratings or view top-rated stocks. What is ANGLE's stock price forecast for 2023? 1 Wall Street analysts have issued 1-year target prices for ANGLE's stock. Their AGL share price forecasts range from GBX 120 to GBX 120. On average, they predict the company's share price to reach GBX 120 in the next year. This suggests a possible upside of 306.8% from the stock's current price. View analysts price targets for AGL or view top-rated stocks among Wall Street analysts. How have AGL shares performed in 2023? ANGLE's stock was trading at GBX 50.50 at the start of the year. Since then, AGL stock has decreased by 41.6% and is now trading at GBX 29.50. View the best growth stocks for 2023 here. How were ANGLE's earnings last quarter? ANGLE plc (LON:AGL) announced its quarterly earnings data on Thursday, January, 30th. The company reported ($3.33) earnings per share for the quarter. What other stocks do shareholders of ANGLE own? Based on aggregate information from My MarketBeat watchlists, some companies that other ANGLE investors own include Yamana Gold (YRI), Asiamet Resources (ARS), Dekel Agri-Vision (DKL), Eldorado Gold (ELD), Polo Resources (POL), Silvercorp Metals (SVM), First Majestic Silver (AG), AFPO.L (AFPO), Ariana Resources (AAU) and Alamos Gold (AGI). What is ANGLE's stock symbol? ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL." How do I buy shares of ANGLE? Shares of AGL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is ANGLE's stock price today? One share of AGL stock can currently be purchased for approximately GBX 29.50. How much money does ANGLE make? ANGLE (LON:AGL) has a market capitalization of £76.87 million and generates £1.14 million in revenue each year. How many employees does ANGLE have? The company employs 102 workers across the globe. How can I contact ANGLE? ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The official website for the company is www.angleplc.com. The company can be reached via phone at +44-1483-685830. This page (LON:AGL) was last updated on 2/1/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.